AG
CALA

Algert Global’s Calithera Biosciences, Inc CALA Stock Holding History

Algert Global’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-840
Closed -$11K – 1362
2021
Q4 		$11K Buy
+840
New +$21.1K ﹤0.01% 947
2021
Q1 		– Sell
-1,743
Closed -$171K – 568
2020
Q4 		$171K Buy
1,743
+177
+11% +$15.5K 0.05% 357
2020
Q3 		$108K Hold
1,566
– – 0.03% 358
2020
Q2 		$165K Hold
1,566
– – 0.06% 345
2020
Q1 		$139K Sell
1,566
-38
-2% -$4.53K 0.06% 333
2019
Q4 		$183K Sell
1,604
-510
-24% -$38.4K 0.05% 321
2019
Q3 		$131K Buy
+2,114
New +$169K 0.05% 309

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Algert Global's CALA Position: Q1 2022 in Review

Algert Global sold out of Calithera Biosciences, Inc (CALA) in Q1 2022, closing a stake of 840 shares — an estimated $11K sold.

Algert Global first reported a position in CALA in Q3 2019 and held it in 7 quarters. The position peaked at $183K in Q4 2019. 54 funds tracked by Wall St. Rank hold CALA as of Q1 2022.

  • Algert Global reported no remaining Calithera Biosciences, Inc position as of Q1 2022 after selling out during the quarter.
  • Algert Global sold 840 Calithera Biosciences, Inc shares in Q1 2022, an estimated $11K.
  • Algert Global first reported a position in Calithera Biosciences, Inc in Q3 2019 and held it in 7 quarters.
  • Algert Global's Calithera Biosciences, Inc position peaked at $183K in Q4 2019.
  • 54 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.